Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

COSMOS Pharmaceutical Corporation CSMYF

Set alert

Price alert · CSMYF

All alert types
39.89 USD 0.00 0.00%

At close · Oct 30

39.89 Day range 39.89
37.06 52-week range 48.27
YTD
-17.36%
1 year
-13.40%
Open
39.89
Prev close
39.89
Mkt cap
3.16B
Vol
100
Avg vol
3
EPS
2.59
P/E
15.40
More statistics
Low
39.89
High
39.89
Earnings
Oct 14, 2026

6M chart

Chart tools
Interval
1m5m15m30m

Events in this range
  • May 29, 2026Dividend: 0.2795
  • Jul 13, 2026Earnings: 0.736; estimate 0.737; surprise -0.14%
  • Oct 14, 2026Earnings: —; estimate 0.672; surprise —%
Signals (5)
NameDateAgo
MACD: Sell SignalOct 13, 20262 weeks ago
SMA: BullishSep 23, 20261 month ago
RSI: OverboughtSep 23, 20261 month ago
MACD: Buy SignalJun 4, 20264 months ago
RSI: OversoldMay 11, 20265 months ago

Financial health

Altman Z-Score

3.64 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

6 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E 14.6×
FY 2017: 11.8×FY 2018: 12.0×FY 2019: 11.0×FY 2020: 9.8×FY 2021: 7.9×FY 2022: 10.8×FY 2023: 11.4×FY 2024: 25.0×FY 2025: 16.9×FY 2026: 14.6×
FY 2017 5y median 14.6× FY 2026
P/S 0.4×
FY 2017: 0.4×FY 2018: 0.4×FY 2019: 0.3×FY 2020: 0.3×FY 2021: 0.3×FY 2022: 0.3×FY 2023: 0.3×FY 2024: 0.6×FY 2025: 0.5×FY 2026: 0.4×
FY 2017 5y median 0.4× FY 2026
P/B 1.6×
FY 2017: 2.3×FY 2018: 1.9×FY 2019: 1.7×FY 2020: 1.4×FY 2021: 1.2×FY 2022: 1.3×FY 2023: 1.3×FY 2024: 2.6×FY 2025: 2.0×FY 2026: 1.6×
FY 2017 5y median 1.6× FY 2026
P/FCF -40.1×
FY 2017: 26.1×FY 2018: 67.6×FY 2019: 39.5×FY 2020: 5.3×FY 2021: 118×FY 2022: -22.2×FY 2023: 34.8×FY 2024: -965×FY 2025: -610×FY 2026: -40.1×
FY 2017 5y median -40.1× FY 2026
EV/EBITDA 7.2×
FY 2017: 6.4×FY 2018: 6.0×FY 2019: 5.1×FY 2020: 3.8×FY 2021: 3.2×FY 2022: 4.6×FY 2023: 4.9×FY 2024: 11.1×FY 2025: 8.0×FY 2026: 7.2×
FY 2017 5y median 7.2× FY 2026
EV/Sales 0.4×
FY 2017: 0.4×FY 2018: 0.4×FY 2019: 0.3×FY 2020: 0.2×FY 2021: 0.2×FY 2022: 0.3×FY 2023: 0.3×FY 2024: 0.6×FY 2025: 0.5×FY 2026: 0.4×
FY 2017 5y median 0.4× FY 2026
FCF Yield -2.5%
FY 2017: 3.8%FY 2018: 1.5%FY 2019: 2.5%FY 2020: 18.9%FY 2021: 0.8%FY 2022: -4.5%FY 2023: 2.9%FY 2024: -0.1%FY 2025: -0.2%FY 2026: -2.5%
FY 2017 5y median -0.2% FY 2026

Profitability

Gross Margin 20.9%
FY 2017: 19.9%FY 2018: 19.8%FY 2019: 19.9%FY 2020: 19.7%FY 2021: 20.0%FY 2022: 20.0%FY 2023: 20.4%FY 2024: 19.5%FY 2025: 21.1%FY 2026: 20.9%
FY 2017 5y median 20.4% FY 2026
Operating Margin 3.9%
FY 2017: 4.4%FY 2018: 4.1%FY 2019: 4.1%FY 2020: 4.3%FY 2021: 4.6%FY 2022: 3.9%FY 2023: 3.6%FY 2024: 3.3%FY 2025: 4.0%FY 2026: 3.9%
FY 2017 5y median 3.9% FY 2026
Net Margin 2.9%
FY 2017: 3.6%FY 2018: 3.2%FY 2019: 3.1%FY 2020: 3.1%FY 2021: 3.7%FY 2022: 3.1%FY 2023: 2.9%FY 2024: 2.5%FY 2025: 3.1%FY 2026: 2.9%
FY 2017 5y median 2.9% FY 2026
ROE 11.3%
FY 2017: 19.6%FY 2018: 16.2%FY 2019: 15.2%FY 2020: 14.7%FY 2021: 15.9%FY 2022: 12.2%FY 2023: 11.3%FY 2024: 10.6%FY 2025: 12.0%FY 2026: 11.3%
FY 2017 5y median 11.3% FY 2026
ROIC 8.4%
FY 2017: 13.4%FY 2018: 12.3%FY 2019: 12.2%FY 2020: 12.7%FY 2021: 12.6%FY 2022: 10.2%FY 2023: 9.4%FY 2024: 8.5%FY 2025: 9.5%FY 2026: 8.4%
FY 2017 5y median 9.4% FY 2026
ROA 5.4%
FY 2017: 8.1%FY 2018: 7.0%FY 2019: 7.0%FY 2020: 6.7%FY 2021: 8.0%FY 2022: 6.4%FY 2023: 5.7%FY 2024: 5.1%FY 2025: 5.9%FY 2026: 5.4%
FY 2017 5y median 5.7% FY 2026

Growth (YoY)

Revenue 8.8%
FY 2017: 12.4%FY 2018: 11.0%FY 2019: 9.5%FY 2020: 12.0%FY 2021: 6.1%FY 2022: 4.0%FY 2023: 9.6%FY 2024: 16.6%FY 2025: 4.8%FY 2026: 8.8%
FY 2017 FY 2026
Operating Income 4.9%
FY 2017: 19.2%FY 2018: 2.3%FY 2019: 8.9%FY 2020: 17.4%FY 2021: 13.9%FY 2022: -10.1%FY 2023: 1.1%FY 2024: 4.6%FY 2025: 28.3%FY 2026: 4.9%
FY 2017 FY 2026
EPS (diluted) 3.6%
FY 2017: 46.5%FY 2018: -3.2%FY 2019: 8.8%FY 2020: 11.7%FY 2021: 26.7%FY 2022: -14.7%FY 2023: 2.8%FY 2024: -48.6%FY 2025: 26.7%FY 2026: 3.6%
FY 2017 FY 2026
Free Cash Flow -1260.1%
FY 2017: 7902.8%FY 2018: -62.1%FY 2019: 70.3%FY 2020: 640.1%FY 2021: -95.4%FY 2022: -724.1%FY 2023: 169.0%FY 2024: -108.1%FY 2025: -35.3%FY 2026: -1260.1%
FY 2017 FY 2026

Financial Health

Current Ratio 0.8×
FY 2017: 0.6×FY 2018: 0.6×FY 2019: 0.6×FY 2020: 0.7×FY 2021: 0.8×FY 2022: 0.7×FY 2023: 0.7×FY 2024: 0.7×FY 2025: 0.8×FY 2026: 0.8×
FY 2017 5y median 0.7× FY 2026
Quick Ratio 0.4×
FY 2017: 0.3×FY 2018: 0.2×FY 2019: 0.2×FY 2020: 0.4×FY 2021: 0.4×FY 2022: 0.3×FY 2023: 0.3×FY 2024: 0.3×FY 2025: 0.3×FY 2026: 0.4×
FY 2017 5y median 0.3× FY 2026
Debt / Equity 0.3×
FY 2017: 0.2×FY 2018: 0.2×FY 2019: 0.1×FY 2020: 0.1×FY 2021: 0.1×FY 2022: 0.0×FY 2023: 0.1×FY 2024: 0.1×FY 2025: 0.2×FY 2026: 0.3×
FY 2017 5y median 0.1× FY 2026
Net Debt / EBITDA 0.3×
FY 2017: -0.2×FY 2018: -0.1×FY 2019: -0.1×FY 2020: -0.9×FY 2021: -0.9×FY 2022: -0.6×FY 2023: -0.6×FY 2024: -0.3×FY 2025: -0.1×FY 2026: 0.3×
FY 2017 5y median -0.3× FY 2026
Interest Coverage 72.9×
FY 2017: 227×FY 2018: 259×FY 2019: 322×FY 2020: 422×FY 2021: 552×FY 2022: 573×FY 2023: 591×FY 2024: 318×FY 2025: 159×FY 2026: 72.9×
FY 2017 5y median 318× FY 2026

Dividends

Dividend Yield 1.3%
FY 2017: 0.6%FY 2018: 0.8%FY 2019: 0.8%FY 2020: 1.0%FY 2021: 1.1%FY 2022: 1.3%FY 2023: 1.2%FY 2024: 0.8%FY 2025: 0.9%FY 2026: 1.3%
FY 2017 5y median 1.2% FY 2026
Payout Ratio 18.5%
FY 2017: 7.6%FY 2018: 10.1%FY 2019: 9.3%FY 2020: 9.7%FY 2021: 8.4%FY 2022: 14.1%FY 2023: 13.7%FY 2024: 19.1%FY 2025: 16.0%FY 2026: 18.5%
FY 2017 5y median 16.0% FY 2026

Annual · latest fiscal year ends 2026-05-31